Beryl Drugs Limited (BOM:524606)

Market Cap	107.57M
Revenue (ttm)	211.46M
Net Income (ttm)	5.79M
Shares Out	5.07M
EPS (ttm)	1.14
PE Ratio	18.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	693
Average Volume	1,453
Open	20.80
Previous Close	20.80
Day's Range	20.80 - 20.80
52-Week Range	17.35 - 46.00
Beta	0.15
RSI	49.65
Earnings Date	Aug 8, 2025

About Beryl Drugs

Beryl Drugs Limited engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India. The company offers bulk drugs, such as I.V. fluids and small volume injectables, as well as veterinary products. It is also involved in the research and development, and contract manufacturing services. The company also exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524606

Financial Performance

In 2024, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.68%.